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Introduction
Nearly fifteen years ago, some studies performed with 
old scanner generations such as 4- or 16-slice CT have 
shown that coronary CT angiography (CCTA) was a 
promising non-invasive tool for the detection of significant 
coronary stenoses. Particularly, the method has shown 
high sensitivity and excellent negative predictive value for 
ruling out obstructive coronary artery disease (CAD) (1). 
With the introduction in the clinical field of 64-slice CT 
between 2004 and 2006, CCTA started to be considered as 
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an appropriate tool for the evaluation of coronary arteries in 
some specific clinical subsets. As reported by the European 
Society of Cardiology (2), the main clinical application of 
CCTA includes assessment of patients with stable chest pain 
and intermediate pretest likelihood of CAD (3). 
During the last decade, an extensive literature confirmed 
the very high sensitivity, specificity and diagnostic accuracy 
of CCTA for the detection of coronary stenoses when 
compared to invasive coronary angiography (ICA) (4). 
Seven prospective multicenter studies showed the diagnostic 
accuracy of CCTA in patients with suspected but unknown 
CAD (5-10). Apart from the absolute value in diagnostic 
accuracy (in these trials sensitivity and specificity ranged 
between 85% and 99% and 64% and 92%, respectively), the 
diagnostic performance of CCTA is influenced by the pre-
test likelihood of disease. Indeed, this imaging modality is 
associated with higher diagnostic accuracy mainly in patients 
with low-to-intermediate CAD risk (9), while a moderate 
specificity and positive predictive value has been found in 
high-risk patients (11). In them, coronary artery calcification 
(CAC) has been found to be the major underlying reason 
for disagreement between CCTA and quantitative ICA for 
the assessment of coronary lumen obstruction, with CCTA 
limited by a higher rate of overestimation but also by some 
clinically more dangerous cases of underestimation (12). 
However, technology advancements have recently shown 
to improve CCTA diagnostic accuracy, mainly in positive 
predictive value terms, in patients with high CAC and/or 
high pre-test likelihood of CAD. Indeed, scanners equipped 
with improved spatial resolution along the X-Y planes 
partially improved the positive predictive value in patients 
with high prevalence of obstructive CAD (13), while a study 
performed with dual-energy CT and calcium removal by 
material decomposition imaging demonstrated a significant 
increase in specificity and positive predictive value in 
patients with high CAC (14). When compared with other 
non-invasive tests (exercise ECG, stress echocardiography, 
SPECT or PET myocardial perfusion imaging and cardiac 
magnetic resonance), commonly used as gatekeepers to ICA 
in stable symptomatic patients, CCTA has demonstrated 
higher sensitivity and specificity versus exercise ECG (15), 
nuclear imaging (8) and all other stress imaging modalities 
(8,10) in patients with intermediate pre-test probability 
and low prevalence of obstructive CAD (10). These 
results induced most of the people who drafted consensus 
documents, position papers and clinical guidelines to 
consider CCTA as a useful non-invasive tool in different 
clinical setting of patients with low-to-intermediate pre-
test likelihood of CAD and low-to-moderate prevalence 
of obstructive CAD. However, the information provided 
by CCTA was still regarded insufficient to have a clinical 
role for the assessment of patients with diffuse and 
complex CAD and for planning interventional and surgical 
procedures of myocardial revascularization (16-18).
In order to overcome these intrinsic limitation, the 
group of Patrick Serruys evaluated in 2013 the feasibility 
and reproducibility of adapting to CCTA the SYNTAX 
score, a well-recognized ICA-based tool for stratifying 
CAD severity and complexity and for helping in the 
treatment decision-making in multivessel disease patients 
(19-24). Both European and US revascularization 
guidelines have adopted the anatomical SYNTAX score as 
an important tool for establishing the best revascularization 
strategy in patients with complex CAD (with or without 
unprotected left main coronary artery involvement) (25,26). 
However, the absence of clinical variables in SYNTAX 
score calculation is a significant shortcoming of the 
method (27). Indeed, the guidelines state that clinical 
variables should also be taken into account during 
discussion of the multidisciplinary team consisting of a 
clinical cardiologist, a cardiac surgeon, and an interventional 
cardiologist (the so-called “heart team approach”) when 
deciding for the best treatment modality. For this reason, 
a new score (SYNTAX score II) integrating six clinical 
variables (age, gender, creatinine clearance, peripheral 
vascular disease, COPD and left ventricular ejection 
fraction) has been developed. The addition of the patient 
clinical characteristics and comorbidities to the anatomical 
SYNTAX score giving rise to the SYNTAX Score II, 
provided a treatment recommendation based on the 
predicted 4-year mortality in patients undergoing coronary 
artery bypass grafting (CABG) surgery or percutaneous 
coronary intervention (PCI). Based on the SYNTAX Score 
II, in 2013 Serruys et al. created a dedicated nomogram that 
is able to provide a reliable and individualized prediction of 
4-year mortality in patients undergoing CABG or PCI (27). 
Technology advancements in the field of CCTA allowed 
expanding its use to patients with known CAD (28-32), 
thanks to a more accurate assessment of lumen narrowing 
and plaque burden (13,33). However, despite the calculation 
of the CCTA-derived SYNTAX score has been shown to be 
accurate compared to the score resulting from ICA (19), the 
diagnostic performance of the latest CT scanner generation 
and the agreement on treatment decision in patients with 
multivessel CAD remain to be investigated. Therefore, 
the SYNTAX III Revolution trial tried to determine the 
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agreement between separate heart teams on treatment 
recommendation based either on CCTA or ICA in patients 
with three-vessel CAD with or without left main disease (34).
Clinical evidence in favor of CCTA use for 
planning myocardial revascularization
The SYNTAX III Revolution trial was an international, 
multicenter study randomizing separate heart teams to 
make a treatment decision between CABG and PCI, using 
either CCTA or ICA, while blinded to the other imaging 
modality. Patients with three-vessel CAD with or without 
left main involvement but without prior revascularization 
who were diagnosed with either CCTA or ICA and were 
candidates for either CABG or PCI were assessed for 
eligibility (34). In addition to the initial imaging tool used 
for eligibility assessment, patients underwent evaluation 
with the alternative imaging modality. Separate heart 
teams constituted by an interventional cardiologist, a 
cardiac surgeon and a radiologist specialized in cardiac 
imaging were randomized to either assess the coronary 
anatomy with CCTA or ICA in addition to the patient 
clinical information. Each heart team calculated the 
anatomical SYNTAX score based solely on their allocated 
imaging modality and subsequently integrated the clinical 
information to compute the SYNTAX Score II risk 
prediction model providing a treatment recommendation, 
i.e., CABG, PCI, or equipoise between CABG and PCI. 
Patients underwent CCTA with one of the latest CT 
scanner generation, which has a nominal spatial resolution 
of 230 microns along the X-Y planes, a rotational speed 
of 0.28 s, and a Z-plane coverage of 16 cm enabling to 
image the heart in one heartbeat. Severity and extension of 
CAD were assessed using the anatomical SYNTAX score. 
Coronary segments showing narrowing with visual diameter 
stenosis >50% using CCTA or ICA and weighted according 
to their location in the coronary tree were included in the 
calculation. For the primary endpoint, the two local heart 
teams made their decision on the choice of revascularization 
mode based on their clinical and anatomical assessment. 
For the secondary endpoint, fractional flow reserve derived 
from CCTA (FFRCT) was used to calculate the non-
invasive functional SYNTAX score, which was computed 
subtracting non-flow limiting stenoses (FFRCT >0.80) 
from the CCTA-derived anatomical SYNTAX score (35). 
Finally, the non-invasive functional SYNTAX score 
was used to calculate the SYNTAX Score III, which 
conceptually is a combination of coronary anatomy 
complexity with its physiological repercussion and patient 
clinical characteristics and comorbidities. The diagnostic 
accuracy of FFRCT, which is able to identify lesion-specific 
ischemia, has been validated in four prospective multicenter 
trials (36-38). In patients with multivessel disease, FFRCT 
has shown good diagnostic performance with invasive 
pressure-wire assessment as reference in a sub-analysis of 
the SYNTAX II trail (35). Moreover, the extent, severity 
and functional component of CAD can be objectively 
quantified using the functional SYNTAX score, which 
has a higher discrimination for clinical events compared 
to the anatomic SYNTAX score, while reducing inter-
observer variability (35). The main findings of the study (39) 
may be summarized as follows: (I) regarding the primary 
endpoint, the SYNTAX Score II provided a treatment 
recommendation of CABG in 28% of patients with CCTA 
and in 26% with ICA. The agreement concerning the 
recommendation on the type of revascularization between 
imaging modalities was high, as confirmed by the statistical 
nomenclature of Cohens’ kappa showing a coefficient of 
0.82 (95% CI: 0.73–0.90). The mean difference between 
CCTA-derived and ICA-derived SYNTAX Score II was 
−0.01 (limits of agreement −5.1 to 4.9) with a correlation 
coefficient of 0.98 (P<0.001) without systematic or 
proportional differences. Moreover, CABG was selected as 
the revascularization strategy in 164 patients using CCTA 
and in 155 patients with ICA and the heart teams agreed 
on the coronary segments to be revascularized in 81.1% 
of the cases; (II) as regards the secondary endpoint, the 
study demonstrated that (40): (i) by including the non-
invasive functional evaluation with FFRCT, the heart teams 
changed treatment recommendation in 7% of the cases 
and modified the selection of vessels to be revascularized in 
12% as compared to a CCTA assessment alone. Moreover, 
inclusion of FFRCT information on top of ICA changed 
treatment recommendation in 6.6% of the cases and 
modified revascularization planning in 18.3%; (ii) the non-
invasive functional SYNTAX score reclassified 15.5% 
of the patients to a lower SYNTAX score tertile based 
on CCTA and 14% of the patients to a lower SYNTAX 
score tertile based on ICA; (iii) in patients assessed by 
CCTA, FFRCT reduced from 92.3 to 78.8 the percentage 
of patients with hemodynamically significant three-vessel 
CAD; finally, use of the non-invasive functional SYNTAX 
score for the SYNTAX Score II calculation (SYNTAX 
Score III) corrected the overestimation of the predicted 
mortality for PCI at 4 years (40). Of note, the acceptance 
rate for FFRCT analysis in the study was very high (88%), 
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particularly if compared with that reported in other 
prospective multicenter trials. For example, it was 33% in 
the PROMISE trial (41) and 69% in the SYNTAX II (35). 
The high rate of CCTA suitability for FFRCT appears not 
surprising if we consider the scanner used in the SYNTAX 
III trial that combines different technical features, including 
the intracycle motion-correction algorithm, able to reducing 
the impact of motion artefacts on image quality (42). 
Particularly, this novel scanner combines a 0.23 mm spatial 
resolution, that may be effective in the reduction of beam-
hardening artefacts related to heavily calcific plaques, with 
a wide detector allowing 16-cm of Z-axis coverage and 0.28 
seconds of gantry rotation time, allowing the acquisition in 
an axial scan mode of the whole cardiac volume in a single 
heart beat independently from the HR values, potentially 
avoiding motion artifacts due to high or irregular heart 
rate. Accordingly, recent phantom and human studies 
showed this scanner to be able to assess coronary arteries 
with excellent image quality and diagnostic accuracy up 
to HR of 100 bpm during scanning (43,44), including 
patients with rapid atrial fibrillation and HR-related small 
diastolic acquisition window (42,45). However, because 
the presence of atrial fibrillation was an exclusion criterion 
of the SYNTAX III study, this unfavorable heart rhythm 
remains a potential limitation for the use of CCTA in 
patients with complex CAD. In summary, by randomizing 
two heart teams, the SYNTAX III study showed that 
treatment decision-making based on CCTA is in almost 
perfect agreement with the treatment decision derived 
from ICA in patients with three-vessel CAD. Moreover, 
the SYNTAX Score II demonstrated a high degree of 
correlation between the two diagnostic tools, suggesting 
the potential feasibility of treatment decision-making 
based solely on this type of non-invasive imaging modality 
and clinical information. For patients with multivessel 
disease, a multidisciplinary heart team approach is currently 
advocated by the guidelines for treatment decision-
making with a Class I recommendation, level of evidence 
‘C’, in the absence of proof from randomized trial (46). 
The SYNTAX III REVOLUTION is the first trial to 
randomize the heart team and its almost perfect agreement 
upon treatment selection supports the usefulness of CCTA 
in patients with complex CAD. It should be also recognized 
that in the study the heart teams routinely included a 
radiologist in addition to an interventional cardiologist 
and a cardiac surgeon, which differs from the definition 
of a heart team given by the guidelines. Undoubtedly, 
the interaction with the radiologist enhanced image 
interpretation and the decision-making process.
Although these findings are encouraging, some concerns 
remain on CCTA capability to be used for decision-making 
in patients with a high calcific burden of the coronary 
arteries, a frequent condition in complex and diffuse 
CAD, particularly in elderly and diabetic patients. Indeed, 
CCTA images are less accurate and interpretable in these 
settings, often leading to overestimation of lesion severity 
with a negative impact on specificity and accuracy of the 
method (1,47). This issue was addressed by a sub-analysis 
of the SYNTAX III trial showing, as expected, that heavy 
coronary calcifications moderately affect CCTA capability 
to accurately assess the anatomical SYNTAX score, with a 
significantly higher difference between the CCTA-derived 
and ICA-derived anatomical SYNTAX score (difference 
of 5.9 points in heavy calcification patients vs. 1.5 points in 
patients without heavy calcifications, respectively, P=0.004). 
However, despite the discrepancy in the anatomical 
SYNTAX score assessment, agreement on the heart team 
treatment decision did not differ in patients with (Cohen’s 
Kappa 0.79) or without heavy calcifications (Cohen’s 
Kappa 0.84). Similarly, agreement on treatment planning, 
defined as the coronary vessels to be revascularized, was 
high and did not differ between patients with (overall 
vessels concordance 80.3%) or without heavy calcifications 
(overall vessels concordance 82.8%) (48). Despite these 
findings it is important to note that use of CCTA in patients 
with complex CAD remains a promising new scenario 
for this non-invasive modality but lacks of widespread 
acceptance. Indeed, although the recent ESC Guidelines 
on chronic coronary syndrome promoted CCTA in Class 
I of recommendation in patients with suspected CAD, 
the method is still considered as the most appropriate in 
patients with low-to intermediate pretest likelihood of 
CAD, whereas imaging stress tests (echo, CMR, SPECT, 
PET) are preferable in patients at higher risk (49). 
Clinical cases
We report two case examples (Figures 1-5) in which CCTA 
together with FFRCT was used successfully for planning 
PCI. The case shown in Figures 1-3 illustrates the high 
diagnostic accuracy of FFRCT in a patient with multivessel 
CAD, confirming the findings of Collet et al. in a sub-
analysis of the SYNTAX II trial (35). The case presented in 
Figures 4,5 shows how the new dedicated CCTA software 
developed for plaque characterization and quantification is 
able to predict IVUS findings, as demonstrated by a recent 
2040 Andreini et al. Coronary CT angiography for planning myocardial revascularization
© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2020;10(6):2036-2047 | http://dx.doi.org/10.21037/cdt.2019.11.07
Figure 1 CCTA curved multiplanar reconstructions show the presence of two >50% stenoses of the proximal (arrow) and mid (arrow) LAD 
(A), a long stenosis of the proximal LCx (B) and two stenoses in the mid (>50%) and distal part (tight lesion, arrow) of the RCA (C). The 
FFRCT assessment confirmed the functional significance of the stenosis in mid LAD (D) and distal RCA (F), whereas the FFRCT value was 
>0.80 after the lesions in proximal LAD (D), LCx (E) and proximal RCA (F). CCTA, coronary CT angiography; LM, left main coronary 
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study of Conte et al. (33). 
Future directions
The SYNTAX III Revolution study opens new perspectives 
on CCTA use as a tool to provide interventionalists and 
cardiac surgeons with an anatomy and functional non-
invasive road-map for planning myocardial revascularization 
strategies. Moreover, future full automation of the 
SYNTAX III score calculation has the potential to further 
enhance and speed up the decision-making process in 
patients with multivessel disease. The interactive planner, 
which is a new application of FFRCT, may improve 
treatment selection while tailoring procedural strategy 
based on assessment of functional outcome after virtual 
treatment (50). It is relevant to note that, although a 
prototype of the algorithm applied to coronary stents 
suggested a potential usefulness in this clinical field (51), the 
FFRCT calculation is still not validated and available for the 
routine clinical use in patients with stented coronary arteries. 
Although this limitation, a CCTA/FFRCT diagnostic work-
up has been demonstrated to be cost-effective in patients 
with suspected CAD and without history of previous 
coronary revascularization. In the PLATFORM study, at 
one-year follow-up of patients in the planned invasive test 
group, FFRCT guided strategy cost was $8,127 vs. $12,145 
with a usual care strategy (P<0.0001), not accounting for 
the cost of the FFRCT test. The mean costs remained 26% 
lower among the FFRCT patients than among usual care 
patients ($9,036 vs. $12,145, P<0.0001) when factoring in 
the cost of the FFRCT analysis (52). At the present time, the 
major insurance companies in Europe and US recognize the 
reimbursement for FFRCT analysis. However, the FFRCT 
software is proprietary and still not widely available. In 
this novel and growing clinical field, stress myocardial CT 
perfusion (CTP) has been introduced as a new tool for 
evaluating the functional relevance of a coronary stenosis 
(53-57). In the field of complex CAD treated with PCI, 
the ADVANTAGE prospective study recently evaluated 
150 patients with previous coronary stent implantation 
and demonstrated a CTP diagnostic accuracy significantly 
higher than that of CCTA in the territory-based and patient-
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Figure 3 Invasive coronary angiography and invasive FFR assessment of LM-LAD (A), LCx-M branch (B) and RCA (C) show a very good 
agreement of both anatomical and functional invasive assessment with the correspondent non-invasive evaluation by CCTA- FFRCT. LM, 
left main coronary artery; LAD, left anterior descending artery; LCx, left circumflex artery; M, marginal branch; RCA, right coronary artery.
Figure 2 Anatomical (left panel) and functional (right panel) CCTA-derived SYNTAX Score calculations. The anatomical Syntax score 
of 21, derived by the scoring of five lesions (proximal-mid LAD, long lesion in LCx, mid-distal RCA, arrows) was downgraded to 9 points 
only after the incorporation of FFRCT into the functional Syntax score, by the exclusion of proximal LAD (arrow), LCx and proximal RCA 
(arrow) stenoses. The reduced value of the functional Syntax score suggested PCI instead of CABG. LM, left main coronary artery; LAD, 
left anterior descending artery; LCx, left circumflex artery; M, marginal branch; RCA, right coronary artery.
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Figure 4 CCTA curved multiplanar reconstructions show a 70% stenosis of the distal left main coronary artery (A), involving the ostium 
of LCx (B) and a tight stenosis at the ostium of obtuse marginal branch (C, arrow), whereas the RCA was free from >50% stenosis (D). The 
FFRCT assessment confirmed the functional significance of the stenosis in distal LM-ostial LCx (E) and obtuse marginal branch (F), whereas 
the FFRCT values of the RCA were above the ischemia threshold of 0.80 (G). LM, left main coronary artery; LAD, left anterior descending 





















based analyses (92.1% vs. 85.6% and 86.7% vs. 76.7%, 
respectively), using QCA as gold standard. Similarly, CTP 
specificity and diagnostic accuracy were significantly 
higher than those of CCTA when invasive FFR was 
employed as gold standard. Of note, the radiation exposure 
of cardiac CT (CCTA + CTP) was 4.15±1.5 mSv (32). 
To the best of our knowledge, only few studies addressed 
the prognostic role and the cost-effectiveness of CTP. In 
2017, Meinel et al. enrolled 144 patients who underwent 
both CCTA and dynamic CTP. The study showed that 
CTP had incremental predictive value over clinical risk 
factors and detection of CAD with CCTA (58). More 
recently, CCTA, FFRCT and dynamic CTP were evaluated 
in a multicenter trial that included 84 patients. The trial 
demonstrated that myocardial blood flow evaluated by 
dynamic CTP has the highest prognostic value, over 
CCTA and FFRCT, in terms of future major cardiac events 
at 18-month follow-up (59).
The SYNTAX III study raises the question if a cardiac 
surgeon might be confident in using only the non-invasive 
coronary road-map provided by CCTA to plan CABG. 
The intriguing hypothesis was tested first in a theoretical 
feasibility survey study (60), in which six surgeons of 
the SYNTAX III Revolution trial were invited to review 
CCTA scans of 20 patients who previously underwent 
CABG during the course of the trial. Each surgeon had to 
declare whether planning and execution of surgery would 
be feasible and safe with the sole anatomical and functional 
assessment of CCTA as procedural guidance. The results 
of this “live survey” were quite impressive. The opinion of 
the surgeons was that 84% of the cases were eligible for 
surgery without ICA evaluation. Based on these findings, a 
“first-in-man”, proof-of-concept feasibility and safety trial 
has been designed and will enroll 100 patients in whom 
surgeons will perform CABG without having access to ICA. 
Of note, CABG outcome will be assessed by CCTA 30 days 
after surgery in order to evaluate graft patency and correct 
anatomic location of the anastomoses (61). 
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Conclusions
An emerging body of literature indicates that CCTA 
may have a clinical role also in patients with high pretest 
likelihood of CAD, known CAD and complex and diffuse 
disease. In particular, the SYNTAX studies demonstrated 
the usefulness of CCTA as a non-invasive tool for planning 
interventional and surgical coronary procedures, thanks to 
its ability to combine, in a single method, precise stenosis 
quantification, accurate plaque characterization, functional 
assessment and selection of the revascularization modality 
for any individual patient and of the vessels that need to be 
revascularized. It may be reasonable to state that the time 
has come to use CCTA for the assessment and decision 
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